LIBINI-1

Protocol v1

aCRF v1.0
16-May-2025



Software version
Klindat® v1.5

Last update
02-JAN-2023

Liquid biopsy for predicting niraparib benefit in 1st line (LIBINI-1) PART-1: Design and validation of serum proteins and cytokine panels to identify markers associated with response to niraparib as maintenance treatment after first-line platinum-based regimen in patients with advanced ovarian cancer.


Forgot password?

Supported browsers:
Chrome v.75 or superior
Firefox v.57 or superior
Edge v.108 or superior
Other browsers are not supported.



Connection established succesfully to test environment database